| Literature DB >> 18042388 |
Samir Yahiaoui1, Catherine Fagnere, Christelle Pouget, Jacques Buxeraud, Albert-José Chulia.
Abstract
Some natural compounds such as flavonoids are known to possess a moderate inhibitory activity against aromatase, this enzyme being an interesting target for hormone-dependent breast cancer treatment. It has been demonstrated that the modulation of flavonoid skeleton could increase anti-aromatase effect. Therefore, new 7,8-benzoflavanones were synthesized and tested for their activity toward aromatase inhibition. It was observed that the introduction of a benzo ring at position C-7 and C-8 on flavanone skeleton led to new potent aromatase inhibitors, the resulting 7,8-benzoflavanones being until nine times more potent than aminogluthetimide (the first aromatase inhibitor used clinically).Entities:
Mesh:
Substances:
Year: 2007 PMID: 18042388 DOI: 10.1016/j.bmc.2007.10.057
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641